Clinical Trials Directory

Explore 21,535 clinical trials worldwide

Showing 8951-9000 of 21,535 trials

Active filters:Status: Active, not recruiting

Clinical Trials (21,535)

NCT06773754
Fixed-Dose Combination of Bictegravir/Emtricitabine/Tenofovir Alafenamide Taken as 5 Days Per Week
NAActive, not recruiting
60 participants
Started: Jun 14, 2022 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT05418140
Adenomyosis and Pregnancy Outcomes in Women Undergoing Assisted Reproductive Technology Treatment
N/AActive, not recruiting
828 participants
Started: Jun 14, 2022 · Completed: Dec 31, 2025
5 conditions2 sponsors9 locations
NCT05186272
mHealth Mindfulness Intervention for Pregnant Black and Latina Women at Risk of Postpartum Depression
PHASE3Active, not recruiting
600 participants
Started: Jun 14, 2022 · Completed: Dec 31, 2025
2 conditions1 sponsor1 location
NCT05047250
A Study of Atezolizumab in High PD-L1 Expression, Chemotherapy-Naïve Patients With Stage IV Non-Squamous or Squamous Non-Small Cell Lung Cancer
PHASE3Active, not recruiting
60 participants
Started: Jun 14, 2022 · Completed: Aug 30, 2027
1 condition1 sponsor21 locations
NCT05469386
Single and Combined Effects of Behavioral, Academic, and Medication Treatments for ADHD in the Classroom
PHASE4Active, not recruiting
288 participants
Started: Jun 13, 2022 · Completed: Aug 31, 2026
1 condition1 sponsor2 locations
NCT05382156
Non-interventional Study on Osilodrostat in Patients With Endogenous Cushing's Syndrome
N/AActive, not recruiting
206 participants
Started: Jun 13, 2022 · Completed: Aug 31, 2027
1 condition1 sponsor43 locations
NCT05293002
Belgian Study to Assess the Efficacy and Safety of the RESTORER Iliac Stent for Treatment of Aorto-iliac Lesions.
NAActive, not recruiting
131 participants
Started: Jun 13, 2022 · Completed: Dec 31, 2025
1 condition1 sponsor14 locations
NCT05361317
Correction of Hallux Valgus with the Nexis® PECA Bunion Implantable Osteosynthesis Medical Device
NAActive, not recruiting
86 participants
Started: Jun 13, 2022 · Completed: Jun 13, 2026
1 condition1 sponsor4 locations
NCT04626245
Mindfulness & Mechanisms Study
NAActive, not recruiting
150 participants
Started: Jun 13, 2022 · Completed: Jun 30, 2027
1 condition1 sponsor1 location
NCT05279651
Ivabradine for Prevention of Myocardial Injury After Noncardiac Surgery Trial (PREVENT-MINS)
PHASE3Active, not recruiting
2,146 participants
Started: Jun 13, 2022 · Completed: Jun 30, 2026
2 conditions3 sponsors26 locations
NCT05325151
Genetic Counseling Patient Preference Intervention Versus Conventional Genetic Counseling for Women at Elevated Risk for Breast Cancer
NAActive, not recruiting
874 participants
Started: Jun 13, 2022 · Completed: Oct 31, 2025
1 condition2 sponsors1 location
NCT05483985
Evaluation of the Alife Hera System as an Adjunctive Tool for the Prioritization of Embryos Deemed Suitable for Transfer
NAActive, not recruiting
440 participants
Started: Jun 13, 2022 · Completed: Jan 31, 2025
1 condition1 sponsor7 locations
NCT05096195
PRevEnting FracturEs in REnal Disease - 1
PHASE4Active, not recruiting
60 participants
Started: Jun 11, 2022 · Completed: Dec 31, 2025
4 conditions5 sponsors6 locations
NCT05339841
Italian Digital Primary Cardiovascular Prevention Study
NAActive, not recruiting
27,520 participants
Started: Jun 10, 2022 · Completed: Dec 31, 2029
1 condition14 sponsors32 locations
NCT05347134
SKB264 Injection Vs Investigator Selected Regimens to Treat Locally Advanced, Recurrent or Metastatic Triple-negative Breast Cancer
PHASE3Active, not recruiting
254 participants
Started: Jun 10, 2022 · Completed: Mar 31, 2025
1 condition1 sponsor2 locations
NCT06897098
Regeneration of Knee and Ankle Cartilage From Autologous Cartilage Mini-grafts (From the Patient's Own Cells)
PHASE1Active, not recruiting
11 participants
Started: Jun 10, 2022 · Completed: Apr 2, 2025
1 condition1 sponsor3 locations
NCT04941404
A Study of TQ05105 Tablets in Subjects With Glucocorticoid-Refractory Acute Graft-Versus-Host Disease (aGVHD)
PHASE1/PHASE2Active, not recruiting
13 participants
Started: Jun 10, 2022 · Completed: Dec 31, 2024
1 condition1 sponsor4 locations
NCT05211232
Neoadjuvant and Adjuvant Tislelizumab for Nasopharyngeal Carcinoma
PHASE3Active, not recruiting
450 participants
Started: Jun 10, 2022 · Completed: May 30, 2028
1 condition5 sponsors4 locations
NCT05329766
A Safety and Efficacy Study of Treatment Combinations With and Without Chemotherapy in Adult Participants With Advanced Upper Gastrointestinal Tract Malignancies
PHASE2Active, not recruiting
332 participants
Started: Jun 10, 2022 · Completed: Jun 30, 2027
1 condition2 sponsors49 locations
NCT05119140
Administration of Hydroxychloroquine (Plaquenil) to African Americans and Hispanics for the Treatment of Mild to Severe Ulcerative Colitis
PHASE1/PHASE2Active, not recruiting
3 participants
Started: Jun 10, 2022 · Completed: May 31, 2025
1 condition2 sponsors2 locations
NCT05022901
An Open-Label Expanded Access Study of the Melphalan/Hepatic Delivery System (HDS) in Patients With Hepatic Dominant Ocular Melanoma
PHASE3Active, not recruiting
30 participants
Started: Jun 10, 2022 · Completed: Mar 1, 2024
2 conditions1 sponsor5 locations
NCT05156710
BIVV020 (SAR445088) n Prevention and Treatment of Antibody-mediated Rejection (AMR)
PHASE2Active, not recruiting
48 participants
Started: Jun 9, 2022 · Completed: Nov 17, 2026
1 condition1 sponsor27 locations
NCT05377684
Study of Quality of Life and Hormone Levels in Premenopausal Participants With Early Breast Cancer Receiving Triptorelin Plus Additional Cancer Treatment
N/AActive, not recruiting
450 participants
Started: Jun 9, 2022 · Completed: Jun 30, 2026
1 condition1 sponsor22 locations
NCT05347225
A Study of Nemtabrutinib (MK-1026) in China Participants With Relapsed or Refractory Hematologic Malignancies (MK-1026-005)
PHASE1Active, not recruiting
12 participants
Started: Jun 9, 2022 · Completed: Apr 30, 2027
1 condition1 sponsor5 locations
NCT05186740
ProVee Urethral Expander System IDE Study (ProVIDE)
NAActive, not recruiting
221 participants
Started: Jun 9, 2022 · Completed: Dec 31, 2028
1 condition1 sponsor17 locations
NCT06701240
Evaluating a Strengths-based Community-grounded Intervention
NAActive, not recruiting
199 participants
Started: Jun 8, 2022 · Completed: Aug 31, 2027
4 conditions1 sponsor1 location
NCT05797714
The Effectiveness and Safety of TMF in the Treatment of Chronic Hepatitis B Patients With Normal ALT.
NAActive, not recruiting
200 participants
Started: Jun 8, 2022 · Completed: Apr 15, 2026
2 conditions2 sponsors12 locations
NCT05144256
A Study to Evaluate the Efficacy and Safety of Mitapivat in Pediatric Participants With Pyruvate Kinase Deficiency (PKD) Who Are Regularly Transfused, Followed by a 5-Year Extension Period
PHASE3Active, not recruiting
49 participants
Started: Jun 8, 2022 · Completed: Jun 30, 2029
2 conditions1 sponsor22 locations
NCT05462379
Autologous Heterotopic Fresh Ovarian Graft in Woman With LACC Eligible for Pelvic Radiotherapy Treatment.
PHASE1/PHASE2Active, not recruiting
22 participants
Started: Jun 8, 2022 · Completed: Apr 1, 2027
2 conditions1 sponsor1 location
NCT05969314
To Check Safety of Ayurvedic Oral Cannabis in Breast and Head and Neck Cancer
PHASE1Active, not recruiting
12 participants
Started: Jun 8, 2022 · Completed: Jun 30, 2025
2 conditions1 sponsor2 locations
NCT06282549
Study to Evaluate the Efficacy and Safety of TEL/AML/CTD in Elderly Patients with Essential Hypertension
N/AActive, not recruiting
1,219 participants
Started: Jun 8, 2022 · Completed: Mar 31, 2027
1 condition1 sponsor5 locations
NCT05294172
KL-A167 Injection Combined With Cisplatin and Gemcitabine vs Placebo Combined With Cisplatin and Gemcitabine in the Treatment of Recurrent or Metastatic Nasopharyngeal Carcinoma
PHASE3Active, not recruiting
295 participants
Started: Jun 7, 2022 · Completed: Dec 31, 2027
2 conditions1 sponsor1 location
NCT05418478
The Effect of Education Given to Patients With Heart Failure on Self-care, Drug Compliance and Quality of Life.
NAActive, not recruiting
80 participants
Started: Jun 7, 2022 · Completed: Sep 10, 2025
1 condition1 sponsor1 location
NCT05268003
A Phase II Study of the Combination of Ponatinib With Mini-hyper CVD Chemotherapy and Venetoclax in Patients With Relapsed or Refractory T-cell Acute Lymphoblastic Leukemia
PHASE2Active, not recruiting
26 participants
Started: Jun 7, 2022 · Completed: Oct 5, 2026
2 conditions1 sponsor1 location
NCT05304416
Clinical Markers of Dysphagia in Cardiac Surgical Patients
N/AActive, not recruiting
347 participants
Started: Jun 7, 2022 · Completed: Dec 31, 2026
2 conditions3 sponsors2 locations
NCT05396833
Study of Tuvusertib (M1774) in Combination With DNA Damage Response Inhibitor or Immune Checkpoint Inhibitor (DDRiver Solid Tumors 320)
PHASE1Active, not recruiting
120 participants
Started: Jun 7, 2022 · Completed: Apr 3, 2026
1 condition2 sponsors22 locations
NCT05092516
Home-based Brain Stimulation Treatment for Post-acute Sequelae of COVID-19 (PASC)
NAActive, not recruiting
40 participants
Started: Jun 7, 2022 · Completed: Sep 15, 2025
2 conditions1 sponsor1 location
NCT05075759
Testing Counseling and Mobile Health Interventions to Improve Physical Activity and Diet Quality in Survivors of Childhood Cancer
NAActive, not recruiting
374 participants
Started: Jun 6, 2022 · Completed: Dec 31, 2026
2 conditions2 sponsors2 locations
NCT06970015
Demographics, Diagnosis, Management, and Outcomes of Non-occlusive Mesenteric Ischemia.
N/AActive, not recruiting
566 participants
Started: Jun 6, 2022 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT05175105
A Study to Evaluate the Efficacy and Safety of Mitapivat in Pediatric Participants With Pyruvate Kinase Deficiency (PKD) Who Are Not Regularly Transfused, Followed by a 5-Year Extension Period
PHASE3Active, not recruiting
30 participants
Started: Jun 6, 2022 · Completed: Jan 31, 2030
2 conditions1 sponsor19 locations
NCT05394740
Clinical Study of Regorafenib and Nivolumab Plus Chemotherapy
PHASE1/PHASE2Active, not recruiting
30 participants
Started: Jun 6, 2022 · Completed: Nov 30, 2025
3 conditions2 sponsors1 location
NCT05417100
Understanding How Methadone Treatment During Surgery Affects Pain Levels and the Need for Pain Medications After Surgery
PHASE3Active, not recruiting
17 participants
Started: Jun 6, 2022 · Completed: Jun 30, 2026
1 condition1 sponsor1 location
NCT05353478
Reducing Opioid Prescription After Kidney Stone Removal Surgery
N/AActive, not recruiting
80 participants
Started: Jun 6, 2022 · Completed: Aug 31, 2026
1 condition1 sponsor1 location
NCT05413083
Evaluation of Cardiac Function in Acutely Decompensated Cirrhosis
N/AActive, not recruiting
70 participants
Started: Jun 6, 2022 · Completed: Oct 31, 2024
3 conditions1 sponsor1 location
NCT05320406
RElugolix VErsus LeUprolide Cardiac Trial
PHASE2Active, not recruiting
94 participants
Started: Jun 6, 2022 · Completed: Dec 30, 2025
11 conditions3 sponsors4 locations
NCT06760936
Pixantrone as Bridging Therapy to Allogenic Transplant or CAR-T Cell Therapy in DLBCL Patients
N/AActive, not recruiting
15 participants
Started: Jun 6, 2022 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT04733534
An Open-Label Intervention Trial to Reduce Senescence and Improve Frailty in Adult Survivors of Childhood Cancer
PHASE2Active, not recruiting
110 participants
Started: Jun 6, 2022 · Completed: Dec 31, 2027
2 conditions3 sponsors1 location
NCT05387915
Biomarker-Driven Radiation Therapy Dose Reduction After Transoral Robotic Surgery for the Treatment of HPV-Positive Oropharyngeal Cancer
PHASE2Active, not recruiting
33 participants
Started: Jun 6, 2022 · Completed: May 5, 2026
2 conditions2 sponsors3 locations
NCT05322070
Fluocinolone Acetonide Intravitreal Implant 0.18 mg in the Treatment of Chronic Non-Infectious Posterior Segment Uveitis
PHASE4Active, not recruiting
125 participants
Started: Jun 6, 2022 · Completed: Nov 30, 2025
1 condition2 sponsors23 locations
NCT05390216
Impact of Partial Capsule Decortication on Device-related Infection in Patients Receiving Cardiac Implantable Electronic Device Replacement
NAActive, not recruiting
1,016 participants
Started: Jun 5, 2022 · Completed: May 31, 2030
2 conditions1 sponsor1 location